Skip to main content
Premium Trial:

Request an Annual Quote

Genpathway s Transcription Analysis Tech Helps Baylor College Find Breast Cancer Genes

NEW YORK, May 25 (GenomeWeb News) - Researchers at Genpathway and Baylor College of Medicine have used Genpathway's transcription analysis technology to identify genes involved in breast cancer, the San Diego-based company said today.


The scientists used Genpathways's Factor Path assay, one of several transcription-based assays that measure transcription directly, rather than by RNA levels, to identify genes regulated by a protein overexpressed in breast cancer.


The assay identifies genomic DNA sequences that are functionally associated with a particular transcription factor or coregulator and quantifies the binding level of each factor across the genome. Another Genpathway assay, TranscriptionPath, showed that the genes identified are biologically relevant.


The study was published earlier this year in PNAS.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.